KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Assets (2016 - 2025)

Historic Assets for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to $90.1 billion.

  • Amgen's Assets fell 81.64% to $90.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $90.1 billion, marking a year-over-year decrease of 81.64%. This contributed to the annual value of $91.8 billion for FY2024, which is 547.07% down from last year.
  • Amgen's Assets amounted to $90.1 billion in Q3 2025, which was down 81.64% from $87.9 billion recorded in Q2 2025.
  • Amgen's 5-year Assets high stood at $97.2 billion for Q4 2023, and its period low was $59.2 billion during Q1 2022.
  • Over the past 5 years, Amgen's median Assets value was $88.7 billion (recorded in 2023), while the average stood at $78.8 billion.
  • Its Assets has fluctuated over the past 5 years, first plummeted by 805.71% in 2021, then surged by 5223.97% in 2023.
  • Over the past 5 years, Amgen's Assets (Quarter) stood at $61.2 billion in 2021, then increased by 6.47% to $65.1 billion in 2022, then surged by 49.19% to $97.2 billion in 2023, then fell by 5.47% to $91.8 billion in 2024, then fell by 1.85% to $90.1 billion in 2025.
  • Its last three reported values are $90.1 billion in Q3 2025, $87.9 billion for Q2 2025, and $89.4 billion during Q1 2025.